Edition:
United Kingdom

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

514.50INR
5:39am GMT
Change (% chg)

Rs-5.85 (-1.12%)
Prev Close
Rs520.35
Open
Rs522.00
Day's High
Rs528.45
Day's Low
Rs509.00
Volume
425,324
Avg. Vol
453,372
52-wk High
Rs678.80
52-wk Low
Rs434.80

Select another date:

Tue, Nov 13 2018

UPDATE 1-Indian drugmaker Sun Pharma swings to surprise quarterly loss

Nov 13 Sun Pharmaceutical Industries was sent to an unexpected second-quarter loss by a one-off charge for an antitrust litigation settlement.

India's Sun Pharma posts surprise quarterly loss on one-time charge

Nov 13 Sun Pharmaceutical Industries Ltd , India's largest drugmaker by market capitalisation, posted a surprise quarterly loss on Tuesday, hurt by a one-time charge due to a legal settlement.

UPDATE 1-India's Sun Pharma Q1 profit beats estimates as U.S. sales climb

* Stock top gainer on NSE index (Adds details on U.S. and India sales, share movement)

India's Sun Pharma quarterly profit beats estimates

Aug 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates.

India's Sun Pharma says U.S. FDA clears Halol plant

MUMBAI, June 12 India's largest drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday the U.S. Food and Drug Administration (FDA) cleared its Halol drug plant, which had been under supply restrictions due to quality control failures.

Indian shares recover from early losses to end flat

* NSE index ended 0.01 pct down, BSE index closed 0.05 pct lower

Indian shares end higher; banks, oil firms gain

May 28 Indian shares ended higher for a third session on Monday, as lower crude prices and a firmer rupee lifted sentiment, with financial and oil stocks accounting for much of the gains.

Indian shares gain as crude oil slips; Sun Pharma top gainer

May 28 Indian equities gained for a third straight session on Monday as a sharp drop in crude prices and a recovery in the rupee boosted sentiment, while shares of Sun Pharmaceutical Industries saw their best day in over three years on strong fourth-quarter results.

UPDATE 2-India's Sun Pharma warns U.S. pricing pressure to hit 2019 profit

* Plans to reduce "unviable" generics research (Adds managing director comments from conference call)

India's Sun Pharma Industries Q4 profit up 7 pct, beats estimates

May 25 Sun Pharmaceutical Industries Ltd , India's largest drugmaker, posted fourth-quarter net profit way above expectations.

Select another date: